EDSA - Company ID 0001540159
Edesa Biotech, Inc. (EDSA) reported net income of -$7.19M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$7.19M | -16.5% |
| FY 2024 | -$6.17M | +26.3% |
| FY 2023 | -$8.37M | +52.3% |
| FY 2022 | -$17.55M | -31.5% |
| FY 2021 | -$13.34M | -109.7% |
| FY 2020 | -$6.36M | -314.1% |
| FY 2018 | -$1.54M | +69.5% |
| FY 2017 | -$5.03M | -0.1% |
| FY 2016 |
Edesa Biotech, Inc. (EDSA) reported net income of -$7.19M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2012 and fiscal 2025, Edesa Biotech, Inc.'s net income declined from -$5.53M to -$7.19M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$5.03M |
| -76.8% |
| FY 2015 | -$2.84M | +66.3% |
| FY 2014 | -$8.44M | +41.8% |
| FY 2013 | -$14.50M | -162.2% |
| FY 2012 | -$5.53M | - |